RecallHawk
Class II Recall

CDI OneView System BPM Probe: Cat. No. CDI753 - CDI OneView BPM Probe, Cat. No. CDI753TK - CDI OneView BPM Probe Tri

Terumo Cardiovascular Systems Corporation

Summary

The FDA issued a Class II for CDI OneView System BPM Probe: Cat. No. CDI753 - CDI OneView BPM Probe, Cat. by Terumo Cardiovascular Systems Corporation. Reason: Due to an error in assembly of the thermistor within some units, the affected probes will experience inaccuracy in measured shunt sensor temperature. .

Details

Source

Device Recall

External ID

Z-2018-2025

Action Date

2025-07-02

Status

Ongoing

Category

device

Product Description

CDI OneView System BPM Probe: Cat. No. CDI753 - CDI OneView BPM Probe, Cat. No. CDI753TK - CDI OneView BPM Probe Trial Kit

Lot/Code Info: UDI-DI 00886799001889 Lot Number/Serial Number Range: B0050231-B0050240 B0050221-B0050230 B0050211-B0050219 B0050201-B0050209 B0050191-B0050200

Quantity Affected: 28 US; 7 OUS

Reason for Recall

Due to an error in assembly of the thermistor within some units, the affected probes will experience inaccuracy in measured shunt sensor temperature. Additionally, following changes in patient temperature without an in vivo recalibration, affected probes may experience inaccuracy in other measured parameters, including pCO2, pO2, pH, Potassium and calculated parameters, including BE, Bicarbonate, Arterial Oxygen Saturation, Delivered Oxygen, Area Under of the Curve of Delivered Oxygen, Oxygen Consumption, and Oxygen Extraction Ratio, which utilize temperature as an input. Inaccurate data may lead to inappropriate user response.

Distribution

US Nationwide distribution in the states of California, Delaware, Hawaii, Iowa, Indiana, Michigan, North Carolina, New York, Ohio, and Washington. The country of New Zealand.

Type: Voluntary: Firm initiated

Recall Initiated: 2025-05-28

Context & Analysis

This is a Class II recall. Class II recalls indicate that use of or exposure to the product may cause temporary or medically reversible health consequences, or that the probability of serious consequences is remote.

This was one of 160 device recalls issued in the same week, part of 413 device-related FDA actions this month.

Terumo Cardiovascular Systems Corporation has 10 FDA actions in our database, including 7 recalls and 3 clearances.

Frequently Asked Questions

What is a Class II recall?

A Class II recall means the product may cause temporary or medically reversible adverse health consequences, or the probability of serious adverse consequences is remote. Consumers should discontinue use.

What should I do if I have this product?

Stop using the product. Check the product against the specific lot numbers or identifiers listed in the recall. Contact the manufacturer (Terumo Cardiovascular Systems Corporation) or your retailer for a refund or replacement. If you experienced adverse effects, report them to the FDA via MedWatch.

How often does Terumo Cardiovascular Systems Corporation have FDA actions?

Terumo Cardiovascular Systems Corporation has 10 FDA actions in our database, including 7 recalls and 3 device clearances.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "Z-2018-2025" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for device

Related Actions